Ingredients

ChargePoint butterfly valve safely handles APIs

29-Jun-2020 By Jenni Spinner

The company’s PharmaSafe containment split butterfly valve is designed for safe handling of non-sterile API and formulation ingredients.

AI Vivo: dexamethasone shows promise as COVID-19 treatment

25-Jun-2020 By Jenni Spinner

The AI-focused pharma technology company reports researchers have determined the drug could save the lives of critically ill COVID-19 patents.

FDA advises API makers on COVID-19 safe practices

24-Jun-2020 By Jenni Spinner

The agency's latest guidance offers advice on keeping manufacturing of active pharmaceutical ingredients safe during the COVID-19 pandemic.

Idifarma: Spray-drying highly potent drugs a key growth factor

24-Jun-2020 By Jenni Spinner

The CDMO has begun manufacturing of highly potent APIs at a dedicated area in its GMP plant, geared toward niche products and clinical batches.

HPAPI Summit tackles trends and technology

24-Jun-2020 By Jenni Spinner

The ninth annual event, taking place in Boston mid-November, will feature industry professionals addressing manufacturing practices, regulatory updates and market trends.

Cascade Chemistry to produce API for COVID-19 trial

24-Jun-2020 By Jenni Spinner

Tapped by Renibus Therapeutics, the CDMO will produce the API for clinical trials of investigational drug RBT-9 for an upcoming COVID-19 study.

Evonik launches Resomer Precise custom functional excipients

15-Jun-2020 By Jenni Spinner

The company reportedly is harnessing sophisticated technology to enable process validation of polymers to tight specifications in parenteral drugs.

Sterling Pharma kicks off hydroxychloroquine production

19-May-2020 By Jenni Spinner

The British CDMO will manufacture the API for the potential COVID-19 treatment, and partner Accord Healthcare will manufacture the finished product.

Gilead, Cipla partner on remdesivir expansion

14-May-2020 By Jenni Spinner

The two companies will join forces on wider manufacturing and distribution of the investigational drug, granted an EUA to treat COVID-19 patients.

Quartic.ai, Bright Path Labs to partner on AI-powered API manufacturing

11-May-2020 By Jenni Spinner

The two firms are joining forces to develop AI-based technology for continuous manufacturing of critical APIs necessary for producing crucial small-molecule drugs.